A step further in the analysis of human bile proteome

Journal of Proteome Research

Volumn 10, Issue 4, 2011, Pages 2047-2063

  Farina, Annarita ^a   Dumonceau, Jean Marc ^b   Delhaye, Myriam ^c   Frossard, Jean Louis ^b   Hadengue, Antoine ^b   Hochstrasser, Denis F ^a,b   Lescuyer, Pierre ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c ERASME HOSPITAL   (Belgium)

Author keywords

bile; biliary stenosis; biomarkers; mass spectrometry; pancreatic cancer; proteomics

Indexed keywords

PROTEOME; TUMOR MARKER;

ADULT; ARTICLE; BILE; BILE DUCT OBSTRUCTION; CENTRIFUGATION; FEMALE; HUMAN; IMMUNOBLOTTING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PANCREAS ADENOCARCINOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEOMICS; UNINDEXED SEQUENCE;

BILE; CHROMATOGRAPHY, LIQUID; DATABASES, PROTEIN; DIGESTIVE SYSTEM NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MOLECULAR SEQUENCE DATA; PROTEINS; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 79953715388     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200011b     Document Type: Article

References (50)

1. Arrese, M.; Trauner, M. Molecular aspects of bile formation and cholestasis Trends Mol. Med. 2003, 9, 558-64 (Pubitemid 38017195)
2. Coleman, R. Biochemistry of bile secretion Biochem. J. 1987, 244, 249-61 (Pubitemid 17087087)
3. Hofmann, A. F. Bile Acids: The Good, the Bad, and the Ugly News Physiol. Sci. 1999, 14, 24-9
4. Keulemans, Y. C.; Mok, K. S.; de Wit, L. T.; Gouma, D. J.; Groen, A. K. Hepatic bile versus gallbladder bile: a comparison of protein and lipid concentration and composition in cholesterol gallstone patients Hepatology 1998, 28, 11-6 (Pubitemid 28299979)
5. LaRusso, N. F. Proteins in bile: how they get there and what they do Am. J. Physiol. 1984, 247, G199-205
6. Kristiansen, T. Z.; Maitra, A.; Pandey, A. Proteomics of human bile. In Proteomics of Human Bodyfluids: Principles, Methods, and Applications; Thongboonkerd, V., Ed.; Humana Press Inc.: Totowa, NJ, 2007; pp 399 - 414.
7. Farina, A.; Dumonceau, J. M.; Lescuyer, P. Proteomic analysis of human bile and potential applications for cancer diagnosis Expert Rev. Proteomics 2009, 6, 285-301
8. Reuben, A. Biliary proteins Hepatology 1984, 4, 46S-50S (Pubitemid 14018142)
9. Chen, B.; Dong, J. Q.; Chen, Y. J.; Wang, J. M.; Tian, J.; Wang, C. B.; Zou, S. Q. Two-dimensional electrophoresis for comparative proteomic analysis of human bile Hepatobiliary Pancreat Dis. Int. 2007, 6, 402-6 (Pubitemid 47288125)
10. Farina, A.; Dumonceau, J. M.; Frossard, J. L.; Hadengue, A.; Hochstrasser, D. F.; Lescuyer, P. Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer J. Proteome Res. 2009, 8, 159-69
11. Guerrier, L.; Claverol, S.; Finzi, L.; Paye, F.; Fortis, F.; Boschetti, E.; Housset, C. Contribution of solid-phase hexapeptide ligand libraries to the repertoire of human bile proteins J. Chromatogr., A 2007, 1176, 192-205 (Pubitemid 350184021)
12. Kristiansen, T. Z.; Bunkenborg, J.; Gronborg, M.; Molina, H.; Thuluvath, P. J.; Argani, P.; Goggins, M. G.; Maitra, A.; Pandey, A. A proteomic analysis of human bile Mol. Cell. Proteomics 2004, 3, 715-28 (Pubitemid 39077002)
13. Zhou, H.; Chen, B.; Li, R. X.; Sheng, Q. H.; Li, S. J.; Zhang, L.; Li, L.; Xia, Q. C.; Wang, H. Y.; Zeng, R. Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach Rapid Commun. Mass Spectrom. 2005, 19, 3569-78 (Pubitemid 41691933)
14. Bonney, G. K.; Craven, R. A.; Prasad, R.; Melcher, A. F.; Selby, P. J.; Banks, R. E. Circulating markers of biliary malignancy: opportunities in proteomics? Lancet Oncol. 2008, 9, 149-58 (Pubitemid 351150126)
15. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 1970, 227, 680-5
16. Harsha, H. C.; Kandasamy, K.; Ranganathan, P.; Rani, S.; Ramabadran, S.; Gollapudi, S.; Balakrishnan, L.; Dwivedi, S. B.; Telikicherla, D.; Selvan, L. D.; Goel, R.; Mathivanan, S.; Marimuthu, A.; Kashyap, M.; Vizza, R. F.; Mayer, R. J.; Decaprio, J. A.; Srivastava, S.; Hanash, S. M.; Hruban, R. H.; Pandey, A. A compendium of potential biomarkers of pancreatic cancer PLoS Med. 2009, 6, e1000046
17. Blumenthal, R. D.; Leon, E.; Hansen, H. J.; Goldenberg, D. M. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers BMC Cancer 2007, 7, 2
18. Duxbury, M. S.; Ito, H.; Benoit, E.; Ashley, S. W.; Whang, E. E. CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness Br. J. Cancer 2004, 91, 1384-90 (Pubitemid 39424802)
19. Duxbury, M. S.; Matros, E.; Clancy, T.; Bailey, G.; Doff, M.; Zinner, M. J.; Ashley, S. W.; Maitra, A.; Redston, M.; Whang, E. E. CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions Ann. Surg. 2005, 241, 491-6 (Pubitemid 40299727)
20. Lewis-Wambi, J. S.; Cunliffe, H. E.; Kim, H. R.; Willis, A. L.; Jordan, V. C. Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells Eur. J. Cancer 2008, 44, 1770-9
21. Zhou, D. H.; Trauzold, A.; Roder, C.; Pan, G.; Zheng, C.; Kalthoff, H. The potential molecular mechanism of overexpression of uPA, IL-8, MMP-7 and MMP-9 induced by TRAIL in pancreatic cancer cell Hepatobiliary Pancreat Dis. Int. 2008, 7, 201-9 (Pubitemid 351524067)
22. Tan, X.; Egami, H.; Abe, M.; Nozawa, F.; Hirota, M.; Ogawa, M. Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK-ERK signal transduction pathway J. Clin. Pathol. 2005, 58, 1242-8 (Pubitemid 41752766)
23. Leelawat, K.; Sakchinabut, S.; Narong, S.; Wannaprasert, J. Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy BMC Gastroenterol. 2009, 9, 30
24. Simeone, D. M.; Ji, B.; Banerjee, M.; Arumugam, T.; Li, D.; Anderson, M. A.; Bamberger, A. M.; Greenson, J.; Brand, R. E.; Ramachandran, V.; Logsdon, C. D. CEACAM1, a novel serum biomarker for pancreatic cancer Pancreas 2007, 34, 436-43 (Pubitemid 46725785)
25. Obrink, B. On the role of CEACAM1 in cancer Lung Cancer 2008, 60, 309-12
26. Koopmann, J.; Thuluvath, P. J.; Zahurak, M. L.; Kristiansen, T. Z.; Pandey, A.; Schulick, R.; Argani, P.; Hidalgo, M.; Iacobelli, S.; Goggins, M.; Maitra, A. Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma Cancer 2004, 101, 1609-15 (Pubitemid 39318908)
27. Moniaux, N.; Chakraborty, S.; Yalniz, M.; Gonzalez, J.; Shostrom, V. K.; Standop, J.; Lele, S. M.; Ouellette, M.; Pour, P. M.; Sasson, A. R.; Brand, R. E.; Hollingsworth, M. A.; Jain, M.; Batra, S. K. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia Br. J. Cancer 2008, 98, 1540-7 (Pubitemid 351652327)
28. Bolignano, D.; Donato, V.; Lacquaniti, A.; Fazio, M. R.; Bono, C.; Coppolino, G.; Buemi, M. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene Cancer Lett. 2010, 288, 10-6
29. Zhivkova-Galunska, M.; Adwan, H.; Eyol, E.; Kleeff, J.; Kolb, A.; Bergmann, F.; Berger, M. R. Osteopontin but not osteonectin favors the metastatic growth of pancreatic cancer cell lines Cancer Biol. Ther. 2010, 10, 54-64
30. Ohno, K.; Nishimori, H.; Yasoshima, T.; Kamiguchi, K.; Hata, F.; Fukui, R.; Okuya, K.; Kimura, Y.; Denno, R.; Kon, S.; Uede, T.; Sato, N.; Hirata, K. Inhibition of osteopontin reduces liver metastasis of human pancreatic cancer xenografts injected into the spleen in a mouse model Surg. Today 2010, 40, 347-56
31. Kolb, A.; Kleeff, J.; Guweidhi, A.; Esposito, I.; Giese, N. A.; Adwan, H.; Giese, T.; Buchler, M. W.; Berger, M. R.; Friess, H. Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions Cancer Biol. Ther. 2005, 4, 740-6 (Pubitemid 41351173)
32. Atkins, C. D. CA 19-9 and Lewis antigens in pancreatic cancer J. Clin. Oncol 2009, 27, 2572-3; author reply 2573
33. Balzano, G.; Di Carlo, V. Is CA 19-9 useful in the management of pancreatic cancer? Lancet Oncol. 2008, 9, 89-91 (Pubitemid 351150124)
34. Daram, S. R. CA 19-9: not a magic marker for pancreatic cancer South Med. J. 2006, 99, 205
35. Kanetaka, K.; Sakamoto, M.; Yamamoto, Y.; Yamasaki, S.; Lanza, F.; Kanematsu, T.; Hirohashi, S. Overexpression of tetraspanin CO-029 in hepatocellular carcinoma J. Hepatol. 2001, 35, 637-42 (Pubitemid 33078274)
36. Gesierich, S.; Paret, C.; Hildebrand, D.; Weitz, J.; Zgraggen, K.; Schmitz-Winnenthal, F. H.; Horejsi, V.; Yoshie, O.; Herlyn, D.; Ashman, L. K.; Zoller, M. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility Clin. Cancer Res. 2005, 11, 2840-52 (Pubitemid 40525182)
37. Novotny, I.; Dite, P.; Dastych, M.; Zakova, A.; Trna, J.; Novotna, H.; Nechutova, H. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer Hepatogastroenterology 2008, 55, 1475-7
38. Kumar, Y.; Mazurek, S.; Yang, S.; Failing, K.; Winslet, M.; Fuller, B.; Davidson, B. R. In vivo factors influencing tumour M2-pyruvate kinase level in human pancreatic cancer cell lines Tumour Biol. 2010, 31, 69-77
39. Hardt, P. D.; Ewald, N. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy Expert Rev. Mol. Diagn. 2008, 8, 579-85
40. Joergensen, M. T.; Heegaard, N. H.; Schaffalitzky de Muckadell, O. B. Comparison of plasma Tu-M2-PK and CA19-9 in pancreatic cancer Pancreas 2010, 39, 243-7
41. Matozaki, T.; Suzuki, T.; Uchida, T.; Inazawa, J.; Ariyama, T.; Matsuda, K.; Horita, K.; Noguchi, H.; Mizuno, H.; Sakamoto, C. Molecular cloning of a human transmembrane-type protein tyrosine phosphatase and its expression in gastrointestinal cancers J. Biol. Chem. 1994, 269, 2075-81 (Pubitemid 24035416)
42. Nagano, H.; Noguchi, T.; Inagaki, K.; Yoon, S.; Matozaki, T.; Itoh, H.; Kasuga, M.; Hayashi, Y. Downregulation of stomach cancer-associated protein tyrosine phosphatase-1 (SAP-1) in advanced human hepatocellular carcinoma Oncogene 2003, 22, 4656-63 (Pubitemid 36976440)
43. Noguchi, T.; Tsuda, M.; Takeda, H.; Takada, T.; Inagaki, K.; Yamao, T.; Fukunaga, K.; Matozaki, T.; Kasuga, M. Inhibition of cell growth and spreading by stomach cancer-associated protein-tyrosine phosphatase-1 (SAP-1) through dephosphorylation of p130cas J. Biol. Chem. 2001, 276, 15216-24
44. Leali, D.; DellEra, P.; Stabile, H.; Sennino, B.; Chambers, A. F.; Naldini, A.; Sozzani, S.; Nico, B.; Ribatti, D.; Presta, M. Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis J. Immunol. 2003, 171, 1085-93 (Pubitemid 36871426)
45. Miyazaki, K.; Hattori, Y.; Umenishi, F.; Yasumitsu, H.; Umeda, M. Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line Cancer Res. 1990, 50, 7758-64
46. Sharom, F. J.; Lehto, M. T. Glycosylphosphatidylinositol-anchored proteins: structure, function, and cleavage by phosphatidylinositol-specific phospholipase C Biochem. Cell. Biol. 2002, 80, 535-49 (Pubitemid 36124815)
47. Yamamoto, Y.; Hirakawa, E.; Mori, S.; Hamada, Y.; Kawaguchi, N.; Matsuura, N. Cleavage of carcinoembryonic antigen induces metastatic potential in colorectal carcinoma Biochem. Biophys. Res. Commun. 2005, 333, 223-9 (Pubitemid 40813468)
48. Gray-Owen, S. D.; Blumberg, R. S. CEACAM1: contact-dependent control of immunity Nat. Rev. Immunol. 2006, 6, 433-46
49. Yue, T.; Goldstein, I. J.; Hollingsworth, M. A.; Kaul, K.; Brand, R. E.; Haab, B. B. The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays Mol. Cell. Proteomics 2009, 8, 1697-707
50. Finzi, L.; Barbu, V.; Burgel, P. R.; Mergey, M.; Kirkwood, K. S.; Wick, E. C.; Scoazec, J. Y.; Peschaud, F.; Paye, F.; Nadel, J. A.; Housset, C. MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder Am. J. Pathol. 2006, 169, 2031-41 (Pubitemid 351181963)